{
    "nctId": "NCT03004261",
    "officialTitle": "Cytomegalovirus Specific Cytotoxic T Lymphocyte for the Treatment of Cytomegalovirus Infection After Allogeneic Hematopoietic Stem Cell Transplantation",
    "inclusionCriteria": "* Any allogeneic stem cell transplant recipient \u2265 14 years of age and \u2264 60 years of age\n* Bilirubin/ SGOT/SGPT \\< 5 \u00d7 upper normal limits.\n* Creatinine \\< 2 \u00d7 upper normal limits.\n* Ejection fraction \u2265 50%, no severe arrhythmia.\n* Estimated life expectancy \u2265 6 months.\n* Patients' CMV-DNA \u2265 1000cp/ml in treatment group and being negative in prophylactic group.\n* Must have minimum age of 14 Years\n* Must have maximum age of 60 Years",
    "exclusionCriteria": "* Patients receiving prednisone \u2265 1mg/kg/d for the treatment of acute GVHD or mild, severe chronic GVHD.\n* Recipient \\< 14years of age\n* Donor is sero-positive in HBV/HCV/HIV or RPR."
}